Herpes Zoster News and Research

RSS
Herpes Zoster, also called shingles, is a painful skin rash caused by the varicella-zoster virus, the same virus that causes chickenpox. After a person recovers from chickenpox, the virus remains inactive in the body. Usually the virus does not cause any further problems; however, the virus may re-emerge years later, causing shingles.
Shingles becoming more common in Australia

Shingles becoming more common in Australia

Broad spectrum sunscreens needed to block UVB and UVA

Broad spectrum sunscreens needed to block UVB and UVA

Cancer fears allayed for shingles patients

Cancer fears allayed for shingles patients

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Novartis receives EC approval for Jakavi to treat myelofibrosis

Novartis receives EC approval for Jakavi to treat myelofibrosis

Top-line results from Pfizer's tofacitinib Phase 3 study on moderate-to-severe active RA

Top-line results from Pfizer's tofacitinib Phase 3 study on moderate-to-severe active RA

Once-daily Gralise significantly reduces pain intensity in PHN patients

Once-daily Gralise significantly reduces pain intensity in PHN patients

Herpes zoster vaccine recommendations questioned in patients on biologics

Herpes zoster vaccine recommendations questioned in patients on biologics

Live zoster vaccine associated with reduced risk of HZ in patients with immune-mediated diseases

Live zoster vaccine associated with reduced risk of HZ in patients with immune-mediated diseases

Shingles vaccine may not increase risk of varicella in people with auto-immune diseases

Shingles vaccine may not increase risk of varicella in people with auto-immune diseases

Anti-TNFs increase risk for herpes zoster infections in IRD patients

Anti-TNFs increase risk for herpes zoster infections in IRD patients

Rheumatism drugs may increase shingles risk

Rheumatism drugs may increase shingles risk

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

Risk of recurrent shingles episode is relatively low: Study

Risk of recurrent shingles episode is relatively low: Study

Herpes zoster vaccine safe and well tolerated: Study

Herpes zoster vaccine safe and well tolerated: Study

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN